Top in ID: RSV seasonality; nasal gel for S. aureus
Click Here to Manage Email Alerts
Respiratory syncytial virus, or RSV, showed signs of returning to its pre-pandemic seasonality this past winter, but researchers cautioned that off-season epidemics are still possible.
“With several RSV prevention products in development, ongoing monitoring of RSV circulation can guide the timing of RSV immunoprophylaxis,” Sarah Hamid, PhD, MPH, an Epidemic Intelligence Service officer at the CDC, and colleagues wrote in MMWR.
It was the top story in infectious disease last week.
Another top story was about an exeporfinium chloride nasal gel that decreased the burden of nasal Staphylococcus aureus, reducing patients’ risk for surgical site infections.
Read these and more top stories in infectious disease below:
RSV’s seasonality returning to normal, new data suggest
New data suggest that RSV may be returning to its pre-COVID-19 seasonality — a winter peak — which could help determine when people should be vaccinated against it, researchers said. Read more.
Novel gel reduces nasal S. aureus burden
An exeporfinium chloride nasal gel called XF-73 was safe for patients and effectively decreased the burden of nasal Staphylococcus aureus, which lessens the risk for surgical site infections, researchers found. Read more.
Monoclonal antibodies significantly reduced risk for COVID-19 hospitalization, death
Treatment with a monoclonal antibody within 2 days of a COVID-19 diagnosis reduced the risk for hospitalization or death by almost 40%, according to a study that assessed patient outcomes over a nearly 2-year period. Read more.
Vaccinating older adults could substantially reduce RSV burden
Vaccinating older adults for respiratory syncytial virus could reduce the burden of disease by millions, according to approximations made by a disease transmission model. Read more.
First breakthrough rabies infection in US reported in immunocompromised man
An 84-year-old man reportedly died from rabies 6 months after being bitten by a bat and receiving timely rabies post-exposure prophylaxis. Read more.